share_log

Precision Diagnostics Market Size to Hit USD 196.45 Bn by 2031: Coherent Market Insights

Precision Diagnostics Market Size to Hit USD 196.45 Bn by 2031: Coherent Market Insights

到2031年,精密診斷市場規模將達到1964.5億美元:一致的市場見解
PR Newswire ·  05/23 22:01

BURLINGAME, Calif., May 23, 2024 /PRNewswire/ -- The global Precision Diagnostics Market size is projected to grow from USD 84.54 billion in 2024 to USD 196.45 billion by 2031, growing at a compound annual growth rate (CAGR) of 12.8% from 2024 to 2031, according to a new report by Coherent Market Insights. The precision diagnostics market is expected to grow owing to advancements in molecular diagnostic technologies and emergence of precision medicine approach. Next-generation sequencing (NGS) has enabled identification of genetic variations associated with diseases. NGS platforms facilitate whole genome sequencing which allows early detection of genetic disorders as well as selection of targeted therapies.

加利福尼亞州伯林蓋姆,2024年5月23日 /PRNewswire/ — 根據Coherent Market Insights的最新報告,預計全球精密診斷市場規模將從2024年的845.4億美元增長到2031年的1964.5億美元,從2024年到2031年,複合年增長率(CAGR)爲12.8%。由於分子診斷技術的進步和精準醫療方法的出現,精準診斷市場預計將增長。下一代測序(NGS)使識別與疾病相關的遺傳變異成爲可能。NGS 平台促進了全基因組測序,從而可以及早發現遺傳疾病並選擇靶向療法。


The Full Study is Readily Available | Get Sample Pages of this Report:


完整研究報告隨時可用 | 獲取本報告的示例頁面:

Market Dynamics:

市場動態:

Rising prevalence of chronic and infectious diseases globally is expected to drive growth of the precision diagnostics market during the forecast period. According to WHO, chronic diseases accounted for approximately 60% of the 57 million global deaths in 2008, and chronic disease mortality is projected to rise by 15% globally between 2010 and 2020. In addition, advancements in genomic technologies have enabled development of precision diagnostics tools to detect various genetic mutations responsible for complex diseases. This is further expected to boost the precision diagnostics market growth.

預計在預測期內,全球慢性病和傳染病患病率的上升將推動精密診斷市場的增長。根據世衛組織的數據,慢性病約佔2008年全球5700萬例死亡人數的60%,預計在2010年至2020年之間,全球慢性病死亡率將增加15%。此外,基因組技術的進步使精確診斷工具的開發成爲可能,以檢測導致複雜疾病的各種基因突變。預計這將進一步促進精密診斷市場的增長。

Precision Diagnostics Market Report Coverage

精密診斷市場報告覆蓋範圍

Report Coverage

Details

Market Revenue in 2024

$84.54 billion

Estimated Value by 2031

$196.45 billion

Growth Rate

Poised to grow at a CAGR of 12.8%

Historical Data

2019–2023

Forecast Period

2024–2031

Forecast Units

Value (USD Million/Billion)

Report Coverage

Revenue Forecast, Competitive Landscape, Growth Factors, and Trends

Segments Covered

By Product, By Technology, By Application,

By Indication:

Geographies Covered

North America, Europe, Asia Pacific, and Rest of World

Growth Drivers

  • Technological advancement
  • Development of companion diagnostics

Restraints & Challenges

  • Stringent government regulations
  • High cost of developing and validating advanced diagnostic technologies

報告覆蓋範圍

細節

2024 年的市場收入

845.4 億美元

到 2031 年的估計價值

1964.5 億美元

增長率

有望以12.8%的複合年增長率增長

歷史數據

2019—2023

預測時段

2024—2031

預測單位

價值(百萬美元/十億美元)

報告覆蓋範圍

收入預測、競爭格局、增長因素和趨勢

涵蓋的細分市場

按產品,按技術,按應用,

按指示劃分:

涵蓋的地理區域

北美、歐洲、亞太和世界其他地區

增長驅動力

  • 技術進步
  • 伴隨診斷的開發

限制與挑戰

  • 嚴格的政府法規
  • 開發和驗證先進診斷技術的成本很高

Market Trends:

市場趨勢:

Growing use of cloud-based technologies in healthcare and increasing adoption of electronic health records by hospitals and diagnostic laboratories are some of the key trends in the precision diagnostics market. Cloud-based precision diagnostic solutions help in securely storing and sharing patient health records across different locations. This allows doctors to access accurate health history of patients from remote locations. Furthermore, incorporation of artificial intelligence and machine learning capabilities in precision diagnostics tools is believed to transform disease diagnosis and management. AI-powered algorithms can help physicians analyze diagnostic data faster and aid in disease detection at an early stage.

精準診斷市場的一些關鍵趨勢是醫療保健中越來越多地使用基於雲的技術,以及醫院和診斷實驗室越來越多地採用電子健康記錄。基於雲的精確診斷解決方案有助於在不同地點安全地存儲和共享患者健康記錄。這使醫生能夠從偏遠地區訪問患者的準確健康記錄。此外,在精密診斷工具中整合人工智能和機器學習功能被認爲可以改變疾病的診斷和管理。人工智能驅動的算法可以幫助醫生更快地分析診斷數據,並有助於在早期階段進行疾病檢測。

The kits and assays and consumables segment dominates the precision diagnostics market, accounting for over 35% market share in 2024. This is due to the widespread adoption of assay kits for precision diagnostics procedures like next-generation sequencing and polymerase chain reaction. assay kits offer standardized reagents and consumables required for diagnostic procedures in a ready-to-use format, simplifying the workflow for labs and diagnostic centers. Key players are focusing on developing a wide range of customized and disease-specific assay kits to expand their diagnostic test menus and cater to unmet needs. The growing demand for easy to use, cost-effective and standardized diagnostic solutions will drive the growth of this segment during the forecast period.

試劑盒、化驗和消耗品細分市場在精密診斷市場佔據主導地位,2024年佔35%以上的市場份額。這是由於新一代測序和聚合酶鏈反應等精確診斷程序的測定試劑盒被廣泛採用。測定試劑盒以即用型形式提供診斷程序所需的標準化試劑和耗材,簡化了實驗室和診斷中心的工作流程。主要參與者正專注於開發各種定製和針對特定疾病的檢測試劑盒,以擴展其診斷測試菜單並滿足未滿足的需求。在預測期內,對易於使用、具有成本效益和標準化的診斷解決方案的需求不斷增長,將推動該細分市場的增長。

Immediate Delivery Available | Buy This Premium Research Report:

可立即交付 | 購買此高級研究報告:

Next-generation sequencing technology is estimated to grow at a robust CAGR of 15% till 2031. The factors responsible for the high growth include the increasing application of NGS in precision oncology for comprehensive genomic profiling of tumors, growing popularity of NGS-based non-invasive prenatal tests, and declining costs of sequencing. NGS allows comprehensive genomic and transcriptomic analysis with far greater speed and precision than traditional technologies. Market players are developing new sequencing systems, kits, and bioinformatics solutions tailored for precision diagnostic applications like liquid biopsy and infectious disease testing. This will further support the adoption of NGS technology in clinical diagnostics.

據估計,到2031年,下一代測序技術將以15%的強勁複合年增長率增長。導致高增長的因素包括越來越多地將NGS應用於精準腫瘤學中,以進行腫瘤的全面基因組分析,基於NGS的無創產前檢查越來越受歡迎,以及測序成本的下降。NGS 允許進行全面的基因組和轉錄組學分析,其速度和精度遠高於傳統技術。市場參與者正在開發新的測序系統、試劑盒和生物信息學解決方案,這些解決方案專爲液體活檢和傳染病檢測等精確診斷應用量身定製。這將進一步支持在臨床診斷中採用NGS技術。

Recent Developments:

最近的事態發展:

In November 2023, Roche announced the launch of the LightCylinder PRO System, based on the established gold standard technology of previous LightCycler Systems.

2023年11月,羅氏宣佈推出基於先前LightCyler Systems既定黃金標準技術的LightCylinder PRO系統。

In June 2023, Diatech Pharmacogenetics, signed a collaborative agreement with Janseen Pharmaceutical NV, to improve access to precision medicine for patients with bladder cancer.

2023 年 6 月,Diatech Pharmacogenetics 與 Janseen Pharmaceutical NV 簽署了一項合作協議,旨在改善膀胱癌患者獲得精準醫療的機會。

Key Market Takeaways:

關鍵市場要點:

The precision diagnostics market is anticipated to witness a CAGR of 12.8% during the forecast period 2024-2031, owing to growing demand for personalized medicine and companion diagnostics.

由於對個性化醫療和伴隨診斷的需求不斷增長,預計在2024-2031年預測期內,精密診斷市場的複合年增長率將達到12.8%。

On the basis of product, the kits and assays and consumables segment is expected to hold a dominant position, accounting for over 35% market share in 2024 due to widespread adoption. On the basis of technology, next-generation sequencing segment is expected to hold a dominant position over the forecast period, growing at a robust CAGR of 15% owing to declining costs and wider applications in precision oncology.

從產品來看,試劑盒、化驗和消耗品細分市場預計將佔據主導地位,由於廣泛採用,到2024年將佔35%以上的市場份額。在技術基礎上,下一代測序細分市場預計將在預測期內佔據主導地位,由於成本下降以及精準腫瘤學領域的廣泛應用,下一代測序細分市場將以15%的強勁複合年增長率增長。

On the basis of application, accurate diagnosis segment dominates due to need for precision tests for correct diagnosis and disease management decisions. On the basis of indication, oncology leads the market owing to increasing dependence on genomic profiling for personalized cancer care.

根據應用,準確的診斷區段占主導地位,這是因爲需要精確的測試才能做出正確的診斷和疾病管理決策。根據適應症,由於越來越依賴基因組分析進行個性化癌症護理,腫瘤學在市場上處於領先地位。

Key players operating in the precision diagnostics market include SomaLogic, Ezra Egnite, PercisionLife, HALO Percision Diagnostics, Danaher Corporation, QuideOrtho Corporation, Precision Diagnostics, Koninklijke Philips N.V., Swiss Precision Diagnostic GmbH. These players are focusing on new product launches, global expansion and mergers & acquisitions to gain market share.

在精密診斷市場運營的主要參與者包括SomaLogic、Ezra Egnite、PercisionLife、HALO Percision Diagnostics、丹納赫公司、QuideOrtho公司、精密診斷、Koninklijke Philips N.V.、瑞士精密診斷有限公司。這些參與者正專注於新產品的發佈、全球擴張和併購,以獲得市場份額。

Get 10% Customization on this Report:

在此報告中獲得 10% 的自定義:

Market Segmentation:

市場細分:

By Product Type:

按產品類型劃分:

  • Kits & Assays
  • Consumables
  • 試劑盒和檢測試劑
  • 消耗品

By Technology Type:

按技術類型劃分:

  • Next-Generation Sequencing
  • Polymerase Chain Reaction
  • Mass Spectrometry
  • Others
  • 下一代測序
  • 聚合酶鏈反應
  • 質譜法
  • 其他

By Application Type:

按應用程序類型劃分:

  • Accurate Diagnosis
  • Personalized Treatment
  • Early Detection and Intervention
  • Others
  • 準確的診斷
  • 個性化治療
  • 早期發現和干預
  • 其他

By Indication Type:

按指示類型劃分:

  • Oncology
  • Cardiovascular
  • Immunology
  • Neurology
  • Infectious Diseases
  • Others
  • 腫瘤學
  • 心血管
  • 免疫學
  • 神經病學
  • 傳染病
  • 其他

By Regional Type:

按地區類型劃分:

  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
  • 北美
    • 美國
    • 加拿大
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 墨西哥
    • 拉丁美洲其他地區
  • 歐洲
    • 德國
    • 英國。
    • 西班牙
    • 法國
    • 意大利
    • 俄國
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 大韓民國
    • 東盟
    • 亞太其他地區
  • 中東
    • 海灣合作委員會國家
    • 以色列
    • 中東其他地區
  • 非洲
    • 南非
    • 北非
    • 中非

Key Players Insights:

主要參與者見解:

  • SomaLogic
  • Ezra
  • Egnite
  • PrecisionLife
  • HALO Precision Diagnostics
  • Danaher Corporation
  • QuidelOrtho Corporation
  • Precision Diagnostics
  • Koninklijke Philips N.V.,
  • Swiss Precision Diagnostics GmbH
  • Precision Diagnostic Laboratory
  • Abbott
  • Cepheid
  • Hologic, Inc.
  • Precision Medicine Group, LLC.
  • Thermo Fisher Scientific
  • Illumina, Inc.
  • SomaLogic
  • 以斯拉
  • Egnite
  • 精確壽命
  • HALO 精確診斷
  • 丹納赫公司
  • QuideLortho 公司
  • 精確診斷
  • Koninklijke Philips N.V.,
  • 瑞士精密診斷有限公司
  • 精密診斷實驗室
  • 雅培
  • Cepheid
  • Hologic, Inc.
  • 精準醫療集團有限責任公司
  • 賽默飛世爾科學
  • Illumina, Inc.

Browse More Insights:

瀏覽更多見解:

  • Office-based Labs Market: Global office-based labs market is estimated to be valued at USD 24.53 Bn in 2024 and is expected to reach USD 40.84 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 7.5% from 2024 to 2031.
  • DNA Test Kits Market: The DNA test kits market is estimated to be valued at USD 1.86 Bn in 2024 and is expected to reach USD 5.40 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 16.4% from 2024 to 2031
  • Hematology Analyzer Market: The hematology analyzer market is estimated to be valued at USD 4.94 Bn in 2024 and is expected to reach USD 8.07 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 7.3% from 2024 to 2031.
  • Smart Pacifier Market: The smart pacifier market is estimated to be valued at USD 442.3 Mn in 2024 and is expected to reach USD 640.2 Mn by 2031, exhibiting a compound annual growth rate (CAGR) of 5.4% from 2024 to 2031.
  • 辦公室實驗室市場: 據估計,到2024年,全球辦公實驗室市場價值爲245.3億美元,預計到2031年將達到408.4億美元,從2024年到2031年,複合年增長率(CAGR)爲7.5%。
  • DNA 測試套件市場: 據估計,到2024年,DNA檢測試劑盒市場價值爲18.6億美元,預計到2031年將達到54.0億美元,從2024年到2031年,複合年增長率(CAGR)爲16.4%
  • 血液學分析儀市場: 據估計,到2024年,血液學分析儀市場的價值爲49.4億美元,預計到2031年將達到80.7億美元,從2024年到2031年,複合年增長率(CAGR)爲7.3%。
  • 智能安撫奶嘴市場: 據估計,到2024年,智能奶嘴市場價值爲4.423億美元,預計到2031年將達到6.402億美元,從2024年到2031年,複合年增長率(CAGR)爲5.4%。

About Us:

關於我們:

Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

Coherent Market Insights是一家全球市場情報和諮詢組織,提供聯合研究報告、定製研究報告和諮詢服務。我們以在航空航天和國防、農業、食品和飲料、汽車、化工和材料等各個領域以及幾乎所有領域和詳盡的子領域提供切實可行的見解和真實的報告而聞名。我們通過高度可靠和準確的報告爲客戶創造價值。我們還致力於在COVID-19之後的各個領域提供見解方面發揮主導作用,並繼續爲我們的客戶提供可衡量、可持續的結果。

Contact Us:

聯繫我們:

Mr. Shah
Senior Client Partner – Business Development
Coherent Market Insights
Phone:
US: +1-206-701-6702
UK: +44-020-8133-4027
Japan: +81-050-5539-1737
India: +91-848-285-0837
Email: [email protected]
Website:
Follow Us: LinkedIn | Twitter

沙阿先生
高級客戶合夥人-業務發展
連貫的市場見解
電話:
我們:+1-206-701-6702
英國:+44-020-8133-4027
日本:+81-050-5539-1737
印度:+91-848-285-0837
電子郵件:[電子郵件保護]
網站:
關注我們:LinkedIn | 推特

Logo:

徽標:

SOURCE Coherent Market Insights

來源《連貫的市場洞察》

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論